statistiche ricercatore

DE LERMA BARBARO, ANDREA

Distribuzione geografica

Continente	#
NA - Nord America	6.929
EU - Europa	5.295
AS - Asia	3.374
SA - Sud America	284
AF - Africa	47
OC - Oceania	12
Continente sconosciuto - Info sul continente non disponibili	5
Totale	15.946

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.743
IT - Italia	2.522
SG - Singapore	1.152
UA - Ucraina	957
CN - Cina	707
VN - Vietnam	546
TR - Turchia	388
SE - Svezia	376
HK - Hong Kong	372
FI - Finlandia	300
DE - Germania	278
BR - Brasile	244
FR - Francia	243
IE - Irlanda	205
GB - Regno Unito	164
RU - Federazione Russa	131
CA - Canada	129
IN - India	86
MX - Messico	46
BD - Bangladesh	25
JP - Giappone	25
PL - Polonia	25
NL - Olanda	21
ZA - Sudafrica	19
ES - Italia	16
IQ - Iraq	15
AR - Argentina	13
BE - Belgio	13
AT - Austria	11
NZ - Nuova Zelanda	9
PK - Pakistan	9
CH - Svizzera	8
LT - Lituania	8
CO - Colombia	7
CZ - Repubblica Ceca	7
NG - Nigeria	7
PY - Paraguay	7
SA - Arabia Saudita	7
UZ - Uzbekistan	7
AE - Emirati Arabi Uniti	5
EG - Egitto	5
EU - Europa	5
KE - Kenya	5
MY - Malesia	5
TN - Tunisia	5
LB - Libano	4
PH - Filippine	4
RS - Serbia	4
AU - Australia	3
DZ - Algeria	3
KR - Corea	3
MA - Marocco	3
PE - Perù	3
VE - Venezuela	3
CL - Cile	2
CR - Costa Rica	2
DK - Danimarca	2
EC - Ecuador	2
GR - Grecia	2
HN - Honduras	2
NP - Nepal	2
OM - Oman	2
PA - Panama	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
AZ - Azerbaigian	1
BB - Barbados	1
BG - Bulgaria	1
BH - Bahrain	1
BY - Bielorussia	1
GL - Groenlandia	1
GY - Guiana	1
ID - Indonesia	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KH - Cambogia	1
MO - Macao, regione amministrativa speciale della Cina	1
PS - Palestinian Territory	1
SY - Repubblica araba siriana	1
TW - Taiwan	1
Totale	15.946

Salva come PNG Salva come JPEG

Città	#
Milan	1.839
Jacksonville	724
Singapore	655
San Jose	626
Ashburn	532
Chandler	529
Fairfield	453
Hong Kong	362
Woodbridge	354
Wilmington	259
Princeton	245
Ann Arbor	229
Izmir	229
Beijing	227
Dallas	218
Nyköping	216
Dublin	205
Dearborn	194
Seattle	194
Houston	180
The Dalles	165
Dong Ket	155
Boardman	147
Cambridge	134
Rome	128
Lauterbourg	116
Como	103
Toronto	99
San Mateo	92
New York	91
Chicago	82
Los Angeles	72
Ho Chi Minh City	67
San Diego	55
Hanoi	50
Helsinki	50
Council Bluffs	45
Orem	42
Guangzhou	39
Ogden	38
Chennai	36
Munich	36
Santa Clara	34
São Paulo	30
Düsseldorf	29
London	28
Mexico City	26
Verona	23
Warsaw	23
Pune	22
Tokyo	22
Hefei	21
Manchester	21
Turku	16
Nanjing	15
Shanghai	14
Brooklyn	13
Johannesburg	13
Amsterdam	12
Brussels	12
Kunming	12
Da Nang	11
Frankfurt am Main	10
Fuzhou	10
Montreal	10
Phoenix	10
Stockholm	10
Atlanta	9
Boston	9
Denver	9
Haiphong	9
Hangzhou	9
Norwalk	9
San Francisco	9
Shenzhen	9
St Petersburg	9
Jinan	8
Poplar	8
Redwood City	8
Zhengzhou	8
Abuja	7
Baghdad	7
Christchurch	7
Curitiba	7
Mumbai	7
New Delhi	7
Ponte Lambro	7
Raleigh	7
Washington	7
Auburn Hills	6
Querétaro	6
Rozzano	6
Villanova D'asti	6
Can Tho	5
Changsha	5
Charlotte	5
Chongqing	5
Dhaka	5
Falls Church	5
Goiânia	5
Totale	10.994

Salva come PNG Salva come JPEG

Nome	#
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	225
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	217
Surface protein components from entomopathogenic nematodes and their symbiotic bacteria: effects on immune responses of the greater wax moth, Galleria mellonella (Lepidoptera: Pyralidae)	206
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	205
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	202
Divergent evolution in the mechanisms controlling major histocompatibility complex class II gene transcription in mouse and human	202
The MHC class II transactivator: prey and hunter in infectious diseases	191
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.	188
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	186
New strategies of mammary cancer vaccination	180
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review)	179
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	176
In Vivo Effects of A Pro-PO System Inhibitor on the Phagocytosis of Xenorhabdus Nematophila in Galleria Mellonella Larvae	174
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	167
Block of Stat-1 activation in macrophages, undergoing bacterial phagocytosis causes CIITA reduced transcription and consequent impaired antigen presentation	163
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2	161
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	156
Analysis of microchimerism in thyroid autoimmune diseases	156
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy	156
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines	156
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis	155
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR	154
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	154
Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and partecipatine in the development of anti-inflammatory functional behavior of phagocytic macrophages	151
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA	149
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1B molecules after mycobacterial phagocytosis	145
The complex liaison between cachexia and tumor burden	145
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells.	144
Physiologic target of the Air-1 trans-activator revealed by stable transfection assay	144
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.	143
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication	142
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	142
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions	142
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis	141
MHC immunoevasins: protecting the pathogen reservoir in infection	139
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy.	139
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	138
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions	138
Therapy-induced antitumor vaccination by targeting tumor necrosis factor  to tumor vessels in combination with melphalan	138
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA)	137
HTLV2 influence on pathways regulating proliferation and death in B cell line BJAB	137
CIITA reduced transcription as the cause of HLA class II downregulation in human macrophages during bacterial phagocytosis	136
The MHC class II transactivator (CIITA): a physiologic inhibitor of HIV1 and HTLV2 retroviral infections	136
Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells	136
Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules	135
A new strategy of tumor vaccination based on tumor cells transduced with the MHC class II transactivator CIITA	135
The MHC class II transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection.	135
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	134
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1	133
Inhibition of human T cell leukemia virus type 2 (HTLV-2) replication by the suppressive action of class II transactivator and nuclear factor Y	132
Tumor rejection and anti-tumor memory to cancer cells of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	131
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	130
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis	130
Regulation of HLA antigen expression in HIV infected cells	128
The utility of introducing a measurement of tumor burden for a better assessment of cancer cachexia.	128
Efficient antigen presentation and T cell activation by MHC class II molecules of CIITA-transfected epatocarcinoma cells	127
The history of discovery of Interleukin-1: A fundamental cytokine of the innate immune response	125
Characterization of an epigenetic variant lacking MHC-II inducibility by IFN-g in the promyelocytic cell line THP-1	125
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	125
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells	125
Control of mammary adenocarcinoma growth in vivo by gene therapy with the MHC class II transactivator CIITA	123
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	123
Evidence for a specific post- transcriptional mechanism controlling the expression of HLA-DQ, but not DR and DP molecules	123
The AIR-1 locus encoded HLA class II transcriptional activator (CIITA) inhibits HIV-1 replication by blocking the function of HIV-1 Tat	123
The HLA class II transcriptional activator (CIITA) blocks the function of HIV-1 Tat and inhibits viral replication	121
Espressione delle molecole HLA di classe II in cellule di epatocarcinoma classe II negative dopo trasfezione del transattivatore CIITA. Acquisizione della capacità di processare e presentare l'antigene	119
Reduced expression of the AIR-1 gene product CIITA as the cause of HLA class II down-modulation in normal human macrophages during bacterial phagocytosis	117
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity.	117
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan	116
Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class-II molecules combined with naked DNA interleukin-12 gene transfer	116
Regolazione dell'espressione dei geni del Complesso Maggiore di Istocompatibilità HLA e di CD4 in cellule infettate da HIV: effetto di TAT	116
The HLA class II transcriptional activator (CIITA) blocks the function of HIV-1 Tat and inhibits viral replication	116
La presentazione antigenica su molecole di II classe HLA è profondamente alterata in seguito a fagocitosi batterica	115
The replication of HTLV-2 and the expression of HLA class II transcriptional activator (CIITA) are inversely correlated	115
Innate and adaptive immune function of the MHC class II transactivator, CIITA, against human tumor retroviruses HTLV-2 and HTLV-1	115
Irradiated CIITA-positive mammary adenocarcinoma cells act as potent anti-tumor preventive vaccine by inducine tumor-specific CD4+ T cell priming and CD8+ T cell effector functions	114
Inibizione della replicazione virale di HIV-1 e HTLV-2 da parte di CIITA il regolatore trascrizionale dell'espressione dell'HLA-II	114
Regulation of HLA antigen expression in phagocytes with mycobacteria	113
HLA class II-dependent antigen presentation is deeply impaired in macrophage reservoir of infection	112
Methylation of CIITA promoter IV causes loss of HLA-II inducibility by gamma-IFN in promyelocytic cells	112
Imaging guided percutaneous microwave ablation of tumors.	112
Inhibition of HTLV-2 viral replication by the MHC class II transcriptional activator (CIITA)	112
Irradiated CIITA-positive mammary adenocarcinoma cells act as effective tumor cell vaccine inducing both tumor-specific CD4+ and CD8+ T immune responses and tumor rejection upon challenge.	111
The immunological basis of therapy-induced antitumor vaccination by targeting Tumor Necrosis Factor a to tumor vessels in combination with melphalan	109
Expression of AIR-1/CIITA transactivator in B cell x plasmacytoma somatic cell hybrids restores HLA-DR and -DP expression, but not -DQ	108
HLA-DQ expression is differently regulated from -DR and -DP	108
Control of tumor growth in vivo by gene therapy with the MHC class II transactivator (CIITA)	108
Reduced expression of the AIR-1 gene product CIITA as the cause of HLA class II down modulation in normal human macrophages during bacterial phagocytosis.	108
The complex liaison between vulnerability to cachexia and tumor burden.	108
Higly stable oligomerization forms of HIV-1 Tat detected by Monoclonal antibodies and requirement of monomeric forms for the transactivating function of the HIV-1 LTR	107
Tumor vaccination by CIITA-mediated MHC-II-expressing neoplastic cells	107
Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA	107
The molecular and cellular basis of tumor rejection after vaccination with mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	107
Regulation of HLA antigen expression in phagocytes treated with mycobacteria	106
Temporal and quantitative relations between CIITA and HLA class II expression	105
Constitutive and inducible expression of HLA class II genes in normal cells is under the control of the AIR-1-encoded CIITA trans-activator	105
The MHC class II transactivator is a strong physiologic antagonist of HIV-1 replication	105
The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in differentiating myelomonocytic cells.	104
Induction of tumor regression by gene transfer of the MHC class II transactivator CIITA	103
The AIR-1 locus-encoded HLA class II transcriptional activator (CIITA) inhibits HIV-1 productive infection by blocking the function of HIV-1 Tat	103
Totale	13.632

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	60.391
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	60.391

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	487	0	0	0	0	0	0	0	0	0	59	138	290
2021/2022	1.101	141	133	106	111	22	19	41	95	53	128	91	161
2022/2023	1.408	151	66	123	167	97	319	0	188	173	37	51	36
2023/2024	2.818	452	438	505	488	499	220	24	25	104	17	2	44
2024/2025	1.712	13	47	320	32	84	70	79	86	221	109	133	518
2025/2026	3.774	307	235	118	553	429	279	1.019	256	393	185	0	0
Totale													15.997